↑ Grab this Headline Animator

CoSign Digital Signatures Speeds Up Processes at Benchmark

ARX, Inc. (Algorithmic Research), a global provider of standards-based electronic signatures, digital signatures, and information assurance solutions, has implemented a CoSign digital-signature solution at Benchmark Biolabs, a specialized laboratory service that helps improve the productivity of vaccine research.

CoSign is ARX's non-forgeable, simple-to-use, standards-based digital-signature solution that allows users to digitally sign documents, records, files, forms, and other electronic transactions. CoSign enables users to sign multiple document-format types with just a click of the mouse, resulting in seamless user adoption and fast deployments.

CoSign is being used by Benchmark's internal QA auditors to sign and seal SOPs and compliance reports dealing with controlled chemical substances that are highly regulated by both the USDA and FDA 21 CFR part 11. Benchmark's Laboratory Information System (LIS) acts as a data repository and generates a vast number of reports and SOPs that document procedures and internal compliance.

"Benchmark Biolabs had both internal and external drivers," said Josh Johnson, Systems Administrator, Facilities Manager at Benchmark Biolabs. "We wanted to speed up the process of signing reports generated from our consulting services, and to comply with various USDA and FDA regulations of internal documentation needed to prove adherence to procedures and compliance.

"Moving these documents to an electronic format required us to have a solution that could also seal the reports against any change."

"Benchmark Biolabs remote consultants are using CoSign to sign Word, Excel and PDF documents," said Rodd Schlerf, Life Science Practice Manager at ARX. "The consultants inspect client's labs/operations; suggest recommendations for improvement, compliance, etc. The final reports are signed and trafficked back and forth between 4 locations (Kansas, Nebraska, Missouri, and New York) for review, sign-off and filing - a process that could only be enhanced by a regulatory-compliant digital signature solution such as CoSign."

About Benchmark Biolabs

Benchmark Biolabs is a progressive company focused on streamlining and supporting the development process for biotechnological and pharmaceutical innovators. Benchmark applies a unique mindset to the development process, offering a modern business strategy aimed at integrating the entire process, from Concept to Commercialization.

Benchmark's team provides analytical, clinical, custom laboratory, regulatory, manufacturing and QC services in order to enhance the efficiency of product development for our clients. Collectively, our scientists are responsible for over 60 issued patents, dozens of USDA and FDA approved products and many groundbreaking technology introductions.

For more information please visit www.arx.com/products/cosign.php

About ARX Inc. (Algorithmic Research)

ARX has 20 years of experience assisting life sciences, healthcare, financial institutions, governmental organizations and commercial sectors to secure and streamline their processes and transactions. The company is a leading global provider of standards-based electronic signature and information assurance solutions. ARX offers a wide range of high-end and state-of-the-art products and services designed to simplify, secure, and accelerate electronic transactions.

ARX products are easy to use and simple to deploy, combining software and hardware solutions for small, medium and large business environments. ARX Inc. is a wholly owned subsidiary of Algorithmic Research Ltd., which went through an MBO process from Cylink Corp, today SafeNet, Inc. (NASDAQ:SFNT). For more information, visit

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Macadamian | New Development | |

---

4875 readers online...

, Local News